Format

Send to

Choose Destination
Microb Cell Fact. 2013 Jul 25;12:72. doi: 10.1186/1475-2859-12-72.

Metabolic engineering of Bacillus subtilis for growth on overflow metabolites.

Author information

1
Pharmaceutical Biotechnology, Institute of Pharmacy, Ernst-Moritz-Arndt-Universität, Felix-Hausdorff-Str, 3, D-17487 Greifswald, Germany.

Abstract

BACKGROUND:

The genome of the important industrial host Bacillus subtilis does not encode the glyoxylate shunt, which is necessary to utilize overflow metabolites, like acetate or acetoin, as carbon source. In this study, the operon encoding the isocitrate lyase (aceB) and malate synthase (aceA) from Bacillus licheniformis was transferred into the chromosome of B. subtilis. The resulting strain was examined in respect to growth characteristics and qualities as an expression host.

RESULTS:

Our results show that the modified B. subtilis strain is able to grow on the C2 compound acetate. A combined transcript, protein and metabolite analysis indicated a functional expression of the native glyoxylate shunt of B. lichenifomis in B. subtilis. This metabolically engineered strain revealed better growth behavior and an improved activity of an acetoin-controlled expression system.

CONCLUSIONS:

The glyoxylate shunt of B. licheniformis can be functionally transferred to B. subtilis. This novel strain offers improved properties for industrial applications, such as growth on additional carbon sources and a greater robustness towards excess glucose feeding.

PMID:
23886069
PMCID:
PMC3728045
DOI:
10.1186/1475-2859-12-72
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center